193 related articles for article (PubMed ID: 38100720)
1. Biomarker potential of the LEF1/TCF family members in breast cancer: Bioinformatic investigation on expression and clinical significance.
Lima BM; Azevedo ALK; Giner IS; Gomig THB; Ribeiro EMSF; Cavalli IJ
Genet Mol Biol; 2023; 46(4):e20220346. PubMed ID: 38100720
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
[TBL] [Abstract][Full Text] [Related]
3. TCF/LEF Transcription Factors: An Update from the Internet Resources.
Hrckulak D; Kolar M; Strnad H; Korinek V
Cancers (Basel); 2016 Jul; 8(7):. PubMed ID: 27447672
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation.
DasGupta R; Fuchs E
Development; 1999 Oct; 126(20):4557-68. PubMed ID: 10498690
[TBL] [Abstract][Full Text] [Related]
5. Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.
Willinger T; Freeman T; Herbert M; Hasegawa H; McMichael AJ; Callan MF
J Immunol; 2006 Feb; 176(3):1439-46. PubMed ID: 16424171
[TBL] [Abstract][Full Text] [Related]
6. Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas.
Bleckmann A; Siam L; Klemm F; Rietkötter E; Wegner C; Kramer F; Beissbarth T; Binder C; Stadelmann C; Pukrop T
Clin Exp Metastasis; 2013 Apr; 30(4):471-82. PubMed ID: 23224985
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of zebrafish tcf7 suggests unexplored domains of Wnt/beta-catenin activity.
Veien ES; Grierson MJ; Saund RS; Dorsky RI
Dev Dyn; 2005 May; 233(1):233-9. PubMed ID: 15765502
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer.
Hovanes K; Li TW; Munguia JE; Truong T; Milovanovic T; Lawrence Marsh J; Holcombe RF; Waterman ML
Nat Genet; 2001 May; 28(1):53-7. PubMed ID: 11326276
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.
Hikasa H; Sokol SY
J Biol Chem; 2011 Apr; 286(14):12093-100. PubMed ID: 21285352
[TBL] [Abstract][Full Text] [Related]
10. Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.
Zhan Y; Feng J; Lu J; Xu L; Wang W; Fan S
J Clin Pathol; 2019 Jun; 72(6):425-430. PubMed ID: 30918012
[TBL] [Abstract][Full Text] [Related]
11. Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies.
Mayer CD; Giclais SM; Alsehly F; Hoppler S
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403323
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.
Santiago L; Daniels G; Wang D; Deng FM; Lee P
Am J Cancer Res; 2017; 7(6):1389-1406. PubMed ID: 28670499
[TBL] [Abstract][Full Text] [Related]
13. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
14. Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.
Mao CD; Byers SW
Crit Rev Eukaryot Gene Expr; 2011; 21(3):207-36. PubMed ID: 22111711
[TBL] [Abstract][Full Text] [Related]
15. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
16. LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer.
Kriegl L; Horst D; Reiche JA; Engel J; Kirchner T; Jung A
J Transl Med; 2010 Nov; 8():123. PubMed ID: 21092222
[TBL] [Abstract][Full Text] [Related]
17. Differential binding of Lef1 and Msx1/2 transcription factors to Dkk1 CNEs correlates with reporter gene expression in vivo.
Lieven O; Dronka J; Burmühl S; Rüther U
PLoS One; 2014; 9(12):e115442. PubMed ID: 25545010
[TBL] [Abstract][Full Text] [Related]
18. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
[TBL] [Abstract][Full Text] [Related]
19. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
20. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.
Eichhoff OM; Weeraratna A; Zipser MC; Denat L; Widmer DS; Xu M; Kriegl L; Kirchner T; Larue L; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Aug; 24(4):631-42. PubMed ID: 21599871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
